Mark Alan Miles - 01 Oct 2024 Form 3 Insider Report for Quipt Home Medical Corp. (QIPT)

Role
Chief Compliance Officer
Signature
/s/ Mark Alan Miles
Issuer symbol
QIPT
Transactions as of
01 Oct 2024
Transactions value $
$0
Form type
3
Filing time
01 Oct 2024, 20:14:32 UTC
Next filing
25 Mar 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding QIPT Stock Option (right to buy) 01 Oct 2024 Common Shares 12,500 $1.11 Direct F1
holding QIPT Stock Option (right to buy) 01 Oct 2024 Common Shares 30,000 $6.27 Direct F2
holding QIPT Stock Option (right to buy) 01 Oct 2024 Common Shares 15,000 $6.14 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The exercise price for this award is denominated in Canadian dollars at 1.50. All these options have vested according to the award agreement and are, as of October 1, 2024, exercisable. Converted from Canadian dollars to United States dollars as of the date hereof at a conversion rate of 0.74 United States dollars per Canadian dollar.
F2 The exercise price for this award is denominated in Canadian dollars at 8.48. All these options have vested according to the award agreement and are, as of October 1, 2024, exercisable. Converted from Canadian dollars to United States dollars as of the date hereof at a conversion rate of 0.74 United States dollars per Canadian dollar.
F3 The exercise price for this award is denominated in Canadian dollars at 8.30. Options to purchase 7,500 Common Shares have vested according to the award agreement and are, as of October 1, 2024, exercisable. Options to purchase 1,250 Common Shares will vest on each of November 20, 2024, February 20, 2025, May 20, 2025, August 20, 2025, November 20, 2025, and February 20, 2026. Converted from Canadian dollars to United States dollars as of the date hereof at a conversion rate of 0.74 United States dollars per Canadian dollar.

Remarks:

Quipt Home Medical Corp. (the "Issuer") has determined that it ceased to be a "foreign private issuer" as of March 31, 2024. As a result, effective October 1, 2024, the Issuer is required to comply with the reporting requirements and use the filing forms applicable to U.S. public companies under U.S. securities laws, including reports required under Section 16 of the U.S. Securities Exchange Act of 1934.